Zhaohui Tang
Welcome,         Profile    Billing    Logout  
 9 Trials 
18 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
He, Yu
NCT06359535: An Economic Study of HSK21542 Injection for Prevention of Postoperative Nausea and Vomiting

Recruiting
4
200
RoW
HSK21542, Placebo
Mengchang Yang
Nausea and Vomiting, Postoperative
11/24
11/24
NCT05397158: Optimization of Intestinal Preparation in Older Patients

Completed
N/A
312
RoW
single administration of low dose polyethylene glycol
Beijing Tongren Hospital
Colonoscopy, Older Adults
06/22
07/22
NCT06331923: Assessing the Effectiveness of Continuous Glucose Monitoring in Enhancing Surgical Outcomes for Patients with Diabetes

Recruiting
N/A
10168
RoW
Continuous glucose monitoring (CGM) device
Beijing Tsinghua Chang Gung Hospital, Peking University International Hospital, Wang Jing Hospital, ZhuHai Hospital, Beijing Hospital, Siyang County Hospital of Traditional Chinese Medicine, Second Hospital of Shanxi Medical University, Henan Provincial Chest Hospital, Fuzhou First Hospital, Pinggu Hospital of Beijing Traditional Chinese Medicine Hospital, The First Affiliated Hospital of Anhui University of Chinese Medicine, The First Affiliated Hospital of Zhengzhou University, Mindong Hospital of Ningde, The Fifth Hospital of Xiamen, People's Hospital of Ningxia Hui Autonomous Region, The First People's Hospital of Changzhou, The Fifth hospital of Deyang, Suzhou Municipal Hospital, Tang-Du Hospital, Yiyang Central Hospital, First Affiliated Hospital of Xinjiang Medical University, Peng Ding Shan Shi Zhong Yi Yi Yuan, Yueyang Central Hospital, The First People's Hospital of Lianyungang, Haimen District Traditional Chinese Medicine Hospital, The 910th Hospital, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Beijing Tiantan Hospital, Affiliated Hospital of Jiangsu University, Liaocheng People's Hospital, Beijing Chao Yang Hospital, Jilin City Hospital of Chemical Industry, Creen Hospital-465, Wuhan Central Hospital, Air Force Military Medical University, China, Shanghai Tong Ren Hospital, Beijing Anzhen Hospital, Emergency General Hospital, Beijing Tongren Hospital, Civil Aviation General Hospital, Peking University Shougang Hospital, The First Affiliated Hospital of Anhui Medical University, Chinese PLA Central Hospital
Comprehensive Complication Index
10/25
12/25
NCT05644548: Retinal Vascular Manifestations in Patients With Common Internal Diseases on OCTA Tomography Angiography

Recruiting
N/A
300
RoW
No intervention
Beijing Tongren Hospital
Hypertension, Diabetes Mellitus, Dyslipidemias
12/23
12/28
Qiu, Yudong
CRGGC, NCT04140552: Chinese Research Group of Gallbladder Cancer

Recruiting
N/A
10000
RoW
Shanghai Jiao Tong University School of Medicine, The First Affiliated Hospital of Anhui Medical University, Anhui Provincial Hospital, First Affiliated Hospital Bengbu Medical College, LanZhou University, Henan Cancer Hospital, The First Affiliated Hospital of Zhengzhou University, The Second Affiliated Hospital of Harbin Medical University, First Affiliated Hospital of Harbin Medical University, Harbin Medical University, The First Hospital of Jilin University, Second Hospital of Jilin University, China-Japan Union Hospital, Jilin University, The First People's Hospital of Changzhou, Changzhou No.2 People's Hospital, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China, The First People's Hospital of Taicang, Wuxi Second People's Hospital, Xuzhou Central Hospital, Second Affiliated Hospital of Suzhou University, Affiliated Hospital of Nantong University, The First People's Hospital of Nantong, The Affiliated Hospital of Xuzhou Medical University, Second Affiliated Hospital of Nanchang University, The First Affiliated Hospital of Nanchang University, Jiangxi Provincial People's Hopital, Shengjing Hospital, Baotou Central Hospital, Qinghai People's Hospital, Changzhi Medical College, The First Affiliated Hospital of Shanxi Medical University, Shanxi Provincial Cancer Hospital, First Affiliated Hospital Xi'an Jiaotong University, Eastern Hepatobiliary Surgery Hospital, Shanghai Fengxian District Central Hospital, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Zhongshan Hospital, Shanghai Pudong Hospital, Central Hospital of Minhang District, Shanghai, Putuo District People's Hospital of Shanghai, Xinhua (Chongming) Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Tianjin Medical University Cancer Hospital, First Affiliated Hospital of Xinjiang Medical University, The First Affiliated Hospital of Kunming Medical College, Yinzhou Hospital Affiliated to Medical School of Ningbo University, Shaoxing Second Hospital, Shaoxing People's Hospital, First Affiliated Hospital of Wenzhou Medical University, Sir Run Run Shaw Hospital, Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Cancer Hospital, Huizhou Municipal Central Hospital, Ningbo No. 1 Hospital, People's Hospital of Hunan Province, Hainan People's Hospital, Taizhou Municipal Hospital, Xinghua City People's Hospital, Tongliao City Hospital, Jiangxi Provincial Cancer Hospital, Shandong Provincial Hospital, Qilu Hospital of Shandong University, The Affiliated Hospital of Qingdao University, Xijing Hospital
Gallbladder Neoplasms
12/22
12/25
NCT06295029: Personalized Medication Software for BCL-2 Inhibitor in AML Patients Using Machine Learning and Genomics

Not yet recruiting
N/A
200
NA
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Acute Myeloid Leukemia
12/27
12/27
NCT05665478: Population Pharmacokinetics/Pharmacodynamics of Carbapenems in Febrile Neutropenia Patients

Not yet recruiting
N/A
100
NA
Dose prediction using population pharmacokinetic models
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Febrile Neutropenia, Pharmacokinetics, Pharmacodynamic, Carbapenems
12/25
12/25
Song, Tianqiang
AdBTC-1, NCT03779035: Adjuvant Chemotherapy for Biliary Tract Cancer After Curative Resection

Recruiting
3
460
RoW
Gemcitabine, Capecitabine
Tianjin Medical University Cancer Institute and Hospital
Cholangiocarcinoma, Gall Bladder Carcinoma
12/20
12/23
ALTN-AK105-III-02, NCT04344158: A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)

Active, not recruiting
3
648
RoW
AK105 Injection, Anlotinib Hydrochloride Capsules, Sorafenib Tosylate Tablets
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Advanced Hepatocellular Carcinoma (HCC)
12/26
12/26
NCT04701060: Camrelizumab Combined With Apatinib for Perioperative Treatment of Resectable Primary Hepatocellular Carcinoma

Completed
2
31
RoW
Camrelizumab:200mg, iv,d1 q2w;apatinib:250mg,po,qd,q2w
Tianjin Medical University Cancer Institute and Hospital
Resectable Hepatocellular Carcinoma
03/24
10/24
NCT04741165: Study of HX008 in Combination With Bevacizumab or Lenvatinib for the Treatment of Advanced Hepatocellular Carcinoma (HCC)

Recruiting
2
72
RoW
HX008, Bevacizumab, AVASTIN®, Lenvatinib, LENVIMA®
Taizhou Hanzhong biomedical co. LTD
Hepatocellular Carcinoma
04/22
10/22
NCT04329429: A Study of RC48-ADC in Subjects With HER2 Overexpressed Metastatic Biliary Tract Cancer

Active, not recruiting
2
57
RoW
RC48-ADC, Recombinant Humanized anti-HER2 Monoclonal Antibody-MMAE Conjugate For Injection
RemeGen Co., Ltd.
Biliary Tract Cancer
11/23
06/24
NCT06057571: Study of TT-00420 (Tinengotinib) in Subjects With Cholangiocarcinoma Who Failed or Relapsed to Chemotherapy and FGFR Inhibitor

Recruiting
2
50
RoW
TT-00420 (tinengotinib)
TransThera Sciences (Nanjing), Inc.
Cholangiocarcinoma Metastatic
06/25
10/25
NCT04482257: Bioequivalence Study of Irinotecan Liposome Injection in Chinese Advanced Pancreatic Cancer.

Recruiting
1
48
RoW
Irinotecan Liposome Injection combined with 5-FU/LV
CSPC Ouyi Pharmaceutical Co., Ltd.
Advanced Pancreatic Cancer
12/20
03/21
NCT06560827: CT011 Autologous CAR-T Cells in Patients With Hepatocellular Carcinoma at Risk of Recurrence After Surgical Resection

Recruiting
1
30
RoW
CT011 CAR-GPC3 T Cells Injection
CARsgen Therapeutics Co., Ltd., Shanghai Zhongshan Hospital
HCC
12/26
06/27
TALENTop, NCT04649489: A Study to Evaluate Efficacy and Safety of Hepatic Resection for Liver Cancer with PVTT, HVTT or IVCTT After Initial Ate/Bev

Active, not recruiting
N/A
501
RoW
Atezolizumab, Bevacizumab, Surgery
Jia Fan
Venous Thrombosis
08/27
03/28
Geng, Zhimin
NCT04078230: Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma

Recruiting
N/A
168
US, RoW
Extend LymphAdenectomy
Second Affiliated Hospital, School of Medicine, Zhejiang University
Intrahepatic Cholangiocarcinoma
12/27
12/27
Wei, Miaoyan
NCT06553846: A Clinial Trial of Lutetium [177Lu]-FAP-75 for the Treatment of Patients With Advanced Solid Tumors

Not yet recruiting
1
50
RoW
Lutetium [177Lu]-FAP-75
Fudan University
Solid Tumors
02/25
08/25

Download Options